Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis

Journal of the American Society of Nephrology

Volumn 17, Issue 4, 2006, Pages 1005-1014

  Yosypiv, Ihor V ^a   Schroeder, Mercedes ^a   El Dahr, Samir S ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSINOGEN; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN; HOX PROTEIN; HOXB7 PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; ENZYME INHIBITION; EXPLANT; IMMUNOHISTOCHEMISTRY; KIDNEY COLLECTING TUBULE; KIDNEY DEVELOPMENT; METANEPHROS; MICRODISSECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; URETER; URETER BUD;

EID: 33645473258     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005080803     Document Type: Article

References (42)

1. Aufderheide E, Chiquet-Ehrismann R, Ekblom P: Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol 105: 599-608, 1987
2. Ekblom P: Developmentally regulated conversion of mesenchyme to epithelium. FASEB J 3: 2141-2150, 1989
3. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1: 335-347, 1988
4. Lisle SJ, Lewis RM, Petry CJ, Ozanne SE, Hales CN, Forhead AJ: Effect of maternal iron restriction during pregnancy on renal morphology in the adult rat offspring. Br J Nutr 90: 33-39, 2003
5. Nagata M, Tanimoto K, Fukamizu A, Kon Y, Sugiyama F, Yagami K, Murakami K, Watanabe T: Nephrogenesis and renovascular development in angiotensinogen-deficient mice. Lab Invest 75: 745-753, 1996
6. Takahashi N, Lopez ML, Cowhig JE Jr, Taylor MA, Hatada T, Riggs E, Lee G, Gomez RA, Kim HS, Smithies O: Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J Am Soc Nephrol 16: 125-132, 2005
7. Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 7: 953-965, 1996
8. Oliverio MI, Kim HS, Ito M, Le T, Audoly L, Best CF, Hiller S, Kluckman K, Maeda N, Smithies O, Coffman TM: Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A 95: 15496-15501, 1998
9. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, Ichikawa I: Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal pheno-types of angiotensinogen nullizygotes. J Clin Invest 101: 755-760, 1998
10. Oshima K, Miyazaki Y, Brock JW, Adams MC, Ichikawa I, Pope JC 4th: Angiotensin type II receptor expression and ureteral budding. J Urol 166: 1848-1852, 2001
11. Garcia-Villalba P, Denkers ND, Wittwer CT, Hoff C, Nelson RD, Mauch TJ: Real-time PCR quantification of AT1 and AT2 angiotensin receptor mRNA expression in the developing rat kidney. Exp Nephrol 94: el54-el59, 2003
12. Iosipiv IV, Schroeder M: A role for angiotensin II AT1 receptors in ureteric bud cell branching. Am J Physiol 285: F199-F207, 2003
13. Iosipiv IV: Cellular expression of the angiotensin type 2 receptor (AT2) during murine organogenesis [Abstract]. J Invest Med 50: 134A, 2002
14. Yosypiv IV, Schroeder M: Role of angiotensin type 2 (AT2) receptor in ureteric bud cell branching morphogenesis in vitro [Abstract]. J Am Soc Nephrol 15: 419A, 2004
15. Karihaloo A, O'Rourke DA, Nickel C, Spokes K, Cantley LG: Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis. J Biol Chem 276: 9166-9173, 2001
16. Voisin L, Foisy S, Giasson E, Lambert C, Moreau P, Meloche S: EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors. Am J Physiol Cell Physiol 283: C446-C455, 2002
17. Seta K, Sadoshima J: Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. J Biol Chem 278: 9019-9026, 2003
18. Barasch J, Pressler L, Connor J, Malik A: A ureteric bud cell line induces nephrogenesis in two steps by distinct signals. Am J Physiol 271: F50-F61, 1996
19. Piscione TD, Phan T, Rosenblum ND: BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways. Am J Physiol 280: F19-F33, 2001
20. Zent R, Bush KT, Pohl ML, Quaranta V, Koshikawa N, Wang Z, Kreidberg JA, Sakurai H, Stuart RO, Nigam SK: Involvement of laminin binding integrins and laminin-5 in branching morphogenesis of the ureteric bud during kidney development. Dev Biol 238: 289-302, 2001
21. Srinivas S, Goldberg MR, Watanabe T, Dagati V, Al-Awqati Q, Costantini F: Expression of green fluorescent protein in the ureteric bud of transgenic mice: A new tool for the analysis of the ureteric bud morphogenesis. Dev Genet 24: 241-251, 1999
22. Miyazaki Y, Tsuchida S, Fogo A, Ichikawa I: The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney Int 55: 1683-1695, 1999
23. Gupta IR, Lapointe M, Yu OH: Morphogenesis during mouse embryonic kidney explant culture. Kidney Int 63: 365-376, 2003
24. Berellini G, Gruciani G, Mannhold R: Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists. J Med Chem 48: 4389-4399, 2005
25. Yosipiv IV, El-Dahr SS: Activation of angiotensin-generating systems in the developing rat kidney. Hypertension 27: 281-286, 1996
26. Watanabe T, Costantini F: Real-time analysis of ureteric bud branching morphogenesis in vitro. Dev Biol 271: 98-108, 2004
27. Sakaguchi K, Okabayashi Y, Kido Y, Kimura S, Matsumura Y, Inushima K, Kasuga M: She phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells. Mol Endocrinol 12: 536-543, 1998
28. Tice DA, Biscardi JS, Nickles AL, Parsons SJ: Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A 96: 1415-1420, 1999
29. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC: Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808, 2001
30. Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG: Angiotensin receptors: Signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol 281: H2337-H2365, 2001
31. Watanabe G, Lee RJ, Albanese C, Rainey WE, Batle D, Pestell RG: Angiotensin II activation of cyclinD1-dependent kinase activity. J Biol Chem 271: 22570-22577, 1996
32. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T: Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273: 8890-8896, 1998
33. Schafer B, Gschwind A, Ullrich A: Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23: 991-999, 2004
34. Bernardini N, Bianchi F, Lupetti M, Dolfi A: Immunohistochemical localization of the epidermal growth factor, transforming growth factor alpha, and their receptor in the human mesonephros and metanephros. Dev Dyn 206: 231-238, 1996
35. Sakurai H, Tsukamoto T, Kjelsberg CA, Cantley LG, Nigam SK: EGF receptor ligands are a large fraction of in vitro branching morphogens secreted by embryonic kidney. Am J Physiol 273: F463-F472, 1997
36. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC: Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 269: 230-234, 1995
37. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, Inagami T: Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96: 2947-2954, 1995
38. Huwiler A, Stabel S, Fabbro D, Pfeilschifter J: Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: Comparison of hypertrophic and hyperplastic agonists. Biochem J 305: 777-784, 1995
39. Saward L, Zahradka P: Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81: 249-257, 1997
40. Tang MJ, Cai Y, Tsai SJ, Wang YK, Dressler GR: Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase. Dev Biol 243: 128-136, 2002
41. Olivares-Reyes JA, Shah BH, Hernandez-Aranda J, Garcia-Gaballero A, Farshori MP, Gatcia-Sainz JA, Catt KJ: Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors. Mol Pharmacol 68: 356-364, 2005
42. Fukizawa J, Booz GW, Hunt RA, Shimizu N, Karoor V, Baker KM, Dostal DE: Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: An autocrine loop for hypertrophy. Hypertension 35: 1191-1196, 2000